The national centre brings together leading clinical and pre-clinical researchers working on the field of Peripheral Artery Disease (PAD), and experts with the experience to implement changes in practice. The principal aims of the centre are to:
1. Facilitate innovative research studies targeted at current management deficiencies of PAD.
2. Facilitate the development of new diagnostic and prognostic biomarkers and therapies for PAD through rigorously designed clinical studies or trials.
3. To develop Australian specific data on the personal and health service burden of peripheral arterial disease (PAD) and the outcome of current treatments.
4. Facilitate adoption of evidence-based practice in the management of patients with PAD.
5. To increase research capacity in PAD through a national collaboration under the CRE in PAD.
6. Promote measures to reduce the incidence of PAD and improve outcomes for patients.
7. Foster high quality future leaders in PAD research through training and mentoring schemes which promotes research skills amongst surgeons, physicians, clinical and basic scientists.
8. Model the current and future economic and health outcome implications of PAD management.
In order to achieve these aims the NCRE has 5 central initiatives:
1. A clinical trial network;
2. A linked clinical and biobank registry;
3. A pre-clinical and clinical study development network;
4. An evidence-based guideline development, implementation and evaluation group
5. A focus on the training and development of PAD specific researchers